CUSIP 10806X102COMBBIOQ4 2025
45 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vanguard Group Inc | 16.86M | $1.29B |
| 2 | Blackrock, Inc. | 14.55M | $1.11B |
| 3 | Viking Global Investors LP | 14.39M | $1.10B |
| 4 | Kohlberg Kravis Roberts & Co. L.P. | 13.26M | $1.01B |
| 5 | Janus Henderson Group PLC | 11.00M | $841.35M |
| 6 | Farallon Capital Management LLC | 9.00M | $688.29M |
| 7 | Aisling Capital Management LP | 5.09M | $389.30M |
| 8 | State Street Corp | 4.96M | $379.61M |
| 9 |
| 4 | Aug 14, 2025 | Viking Global Investors LP | 13D/A | 9.7% | — | SEC |
| 5 | Jul 29, 2025 | The Vanguard Group | 13G/A | 8.7% | 16.48M | SEC |
| 6 | Jul 1, 2025 | Viking Global Investors LP | 13D/A | 9.8% | — | SEC |
| 7 | May 14, 2025 | Kkr Genetic Disorder L.P. | 13D/A | 7.0% | — | SEC |
| 8 | Mar 12, 2025 | Viking Global Investors LP | 13D/A | 11.7% | — | SEC |
| 9 | Mar 7, 2025 | Kkr Genetic Disorder L.P. | 13D/A | 10.1% | — | SEC |
| 10 | Feb 13, 2025 | Neil Kumar | 13G/A | 5.4% | 10.47M | SEC |
See the full Schedule 13D/13G history for Bridgebio Pharma Inc.
Unlock full history| Invesco Ltd. |
| 4.83M |
| $369.55M |
| 10 | Geode Capital Management, LLC | 4.41M | $344.69M |